热门资讯> 正文
Culper Research的短期报告导致ADMA生物制品股价下跌
2026-03-25 02:44
- ADMA Biologics (ADMA) fell 15% amid a short report from Culper Research.
- Culper Research disclosed that it's short shares of ADMA Biologics (ADMA).
- ADMA (ADMA) didn't immediately respond to Seeking Alpha's email request for comment.
More on ADMA Biologics
- ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
- ADMA Biologics: Business Update And My Price Target
- ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ADMA Biologics announces $125M accelerated share repurchase with JPmorgan
- ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。